232 related articles for article (PubMed ID: 20451219)
1. Combination treatment of experimental stroke with Niaspan and Simvastatin, reduces axonal damage and improves functional outcome.
Shehadah A; Chen J; Cui X; Roberts C; Lu M; Chopp M
J Neurol Sci; 2010 Jul; 294(1-2):107-11. PubMed ID: 20451219
[TBL] [Abstract][Full Text] [Related]
2. Niaspan treatment induces neuroprotection after stroke.
Shehadah A; Chen J; Zacharek A; Cui Y; Ion M; Roberts C; Kapke A; Chopp M
Neurobiol Dis; 2010 Oct; 40(1):277-83. PubMed ID: 20554037
[TBL] [Abstract][Full Text] [Related]
3. Niaspan increases axonal remodeling after stroke in type 1 diabetes rats.
Yan T; Chopp M; Ye X; Liu Z; Zacharek A; Cui Y; Roberts C; Buller B; Chen J
Neurobiol Dis; 2012 Apr; 46(1):157-64. PubMed ID: 22266016
[TBL] [Abstract][Full Text] [Related]
4. Niacin treatment of stroke increases synaptic plasticity and axon growth in rats.
Cui X; Chopp M; Zacharek A; Roberts C; Buller B; Ion M; Chen J
Stroke; 2010 Sep; 41(9):2044-9. PubMed ID: 20671245
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in rats.
Shehadah A; Chen J; Cui Y; Zhang L; Roberts C; Lu M; Chopp M
J Neurol Sci; 2011 Oct; 309(1-2):96-101. PubMed ID: 21802695
[TBL] [Abstract][Full Text] [Related]
6. Combination BMSC and Niaspan treatment of stroke enhances white matter remodeling and synaptic protein expression in diabetic rats.
Ye X; Yan T; Chopp M; Zacharek A; Ning R; Venkat P; Roberts C; Chen J
Int J Mol Sci; 2013 Nov; 14(11):22221-32. PubMed ID: 24284395
[TBL] [Abstract][Full Text] [Related]
7. Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats.
Ye X; Chopp M; Cui X; Zacharek A; Cui Y; Yan T; Shehadah A; Roberts C; Liu X; Lu M; Chen J
Exp Neurol; 2011 Dec; 232(2):299-308. PubMed ID: 21963653
[TBL] [Abstract][Full Text] [Related]
8. Niaspan treatment increases tumor necrosis factor-alpha-converting enzyme and promotes arteriogenesis after stroke.
Chen J; Cui X; Zacharek A; Ding GL; Shehadah A; Jiang Q; Lu M; Chopp M
J Cereb Blood Flow Metab; 2009 May; 29(5):911-20. PubMed ID: 19223914
[TBL] [Abstract][Full Text] [Related]
9. Niaspan increases angiogenesis and improves functional recovery after stroke.
Chen J; Cui X; Zacharek A; Jiang H; Roberts C; Zhang C; Lu M; Kapke A; Feldkamp CS; Chopp M
Ann Neurol; 2007 Jul; 62(1):49-58. PubMed ID: 17557352
[TBL] [Abstract][Full Text] [Related]
10. Treatment of stroke with a synthetic liver X receptor agonist, TO901317, promotes synaptic plasticity and axonal regeneration in mice.
Chen J; Zacharek A; Cui X; Shehadah A; Jiang H; Roberts C; Lu M; Chopp M
J Cereb Blood Flow Metab; 2010 Jan; 30(1):102-9. PubMed ID: 19724285
[TBL] [Abstract][Full Text] [Related]
11. Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity.
Lee JK; Kim JE; Sivula M; Strittmatter SM
J Neurosci; 2004 Jul; 24(27):6209-17. PubMed ID: 15240813
[TBL] [Abstract][Full Text] [Related]
12. Delayed administration of a PTEN inhibitor BPV improves functional recovery after experimental stroke.
Mao L; Jia J; Zhou X; Xiao Y; Wang Y; Mao X; Zhen X; Guan Y; Alkayed NJ; Cheng J
Neuroscience; 2013 Feb; 231():272-81. PubMed ID: 23219909
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of Nogo receptor promotes functional recovery by enhancing axonal connectivity after experimental stroke in rats.
Wang T; Wang J; Yin C; Liu R; Zhang JH; Qin X
Brain Res; 2010 Nov; 1360():147-58. PubMed ID: 20828545
[TBL] [Abstract][Full Text] [Related]
14. Niaspan attenuates the adverse effects of bone marrow stromal cell treatment of stroke in type one diabetic rats.
Yan T; Ye X; Chopp M; Zacharek A; Ning R; Venkat P; Roberts C; Lu M; Chen J
PLoS One; 2013; 8(11):e81199. PubMed ID: 24303036
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment of stroke with sub-therapeutic doses of Simvastatin and human umbilical cord blood cells enhances vascular remodeling and improves functional outcome.
Cui X; Chopp M; Zacharek A; Dai J; Zhang C; Yan T; Ning R; Roberts C; Shehadah A; Kuzmin-Nichols N; Sanberg CD; Chen J
Neuroscience; 2012 Dec; 227():223-31. PubMed ID: 23041512
[TBL] [Abstract][Full Text] [Related]
16. Niaspan reduces high-mobility group box 1/receptor for advanced glycation endproducts after stroke in type-1 diabetic rats.
Ye X; Chopp M; Liu X; Zacharek A; Cui X; Yan T; Roberts C; Chen J
Neuroscience; 2011 Sep; 190():339-45. PubMed ID: 21683770
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke.
Shabanzadeh AP; Shuaib A; Wang CX
Brain Res; 2005 Apr; 1042(1):1-5. PubMed ID: 15823246
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke.
Ceprián M; Jiménez-Sánchez L; Vargas C; Barata L; Hind W; Martínez-Orgado J
Neuropharmacology; 2017 Apr; 116():151-159. PubMed ID: 28012949
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic benefit of treatment of stroke with simvastatin and human umbilical cord blood cells: neurogenesis, synaptic plasticity, and axon growth.
Cui X; Chopp M; Shehadah A; Zacharek A; Kuzmin-Nichols N; Sanberg CD; Dai J; Zhang C; Ueno Y; Roberts C; Chen J
Cell Transplant; 2012; 21(5):845-56. PubMed ID: 22405262
[TBL] [Abstract][Full Text] [Related]
20. Calycosin Preserves BDNF/TrkB Signaling and Reduces Post-Stroke Neurological Injury after Cerebral Ischemia by Reducing Accumulation of Hypertrophic and TNF-α-Containing Microglia in Rats.
Hsu CC; Kuo TW; Liu WP; Chang CP; Lin HJ
J Neuroimmune Pharmacol; 2020 Jun; 15(2):326-339. PubMed ID: 31927682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
